, /PRNewswire/ -- Colorado Biolabs, Inc. (CBL) and Overseas Healthcare Ltd (Overseas) are pleased to officially announce the launch of for residents of . The product contains CBL's Proferrin brand Heme iron polypeptide and will be available for purchase in 2024.
"Anemia rates in are staggering. Both companies have had the goal of helping residents of for a while now, and we're thrilled to start helping those who need Proferrin and this year," says Colorado Biolabs CEO . Overseas Healthcare, a leading Indian Pharma Company, endeavors to make Proferrin available across the African continent by the end of 2025 under their brand name .
"We at Overseas want to extend the great benefits of our product to all those who suffer from Anemia in and ," says Mr. D.P.
Soni, MD, Overseas Healthcare. CBL's Proferrin brand HIP has demonstrated the ability to increase serum iron up to 23x greater than does a traditional iron salt on a milligram per milligram basis.[1] This allows for excellent iron supplementation using far less iron, leading to a stellar GI side effect profile.
Additionally, HIP absorption does not require acidification via addition of Vitamin C. This fact is important because co-administration of Iron and Vitamin C have been associated with oxidative stress in the gastric mucosa, which can lead to ulceration.[2] Proferrin brand HIP is manufactured in by Colorado Biolabs, Inc.
and Proferrin iron supplements were introduced into the U.S. market in 2001.
Proferrin is also avail.
